No-reflow phenomenon

被引:6
作者
Hellstrom, HR [1 ]
机构
[1] SUNY Upstate Med Univ, Syracuse, NY USA
关键词
D O I
10.1161/01.CIR.0000037128.03240.41
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E143 / E143
页数:1
相关论文
共 50 条
[31]   INVESTIGATIONS OF THE NO-REFLOW PHENOMENON IN ISCHEMIC MYOCARDIUM [J].
GAVIN, JB ;
HUMPHREY, SM ;
ARMIGER, LC ;
SEELYE, RN ;
HERDSON, PB .
NEW ZEALAND MEDICAL JOURNAL, 1981, 93 (686) :442-442
[32]   BENEFICIAL EFFECT OF DEXAMETHASONE ON NO-REFLOW PHENOMENON [J].
ROBERTS, BH ;
NELLIS, SH ;
FIELD, J ;
ZELIS, R .
CIRCULATION, 1976, 54 (04) :160-160
[33]   No-Reflow Phenomenon and Endothelial Glycocalyx of Microcirculation [J].
Maksimenko, Alexander V. ;
Turashev, Askar D. .
BIOCHEMISTRY RESEARCH INTERNATIONAL, 2012, 2012
[34]   Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon [J].
Joseph Allencherril ;
Hani Jneid ;
Dan Atar ;
Mahboob Alam ;
Glenn Levine ;
Robert A. Kloner ;
Yochai Birnbaum .
Cardiovascular Drugs and Therapy, 2019, 33 :589-597
[35]   NO-REFLOW PHENOMENON IN EXPERIMENTAL FREE FLAPS [J].
MAY, JW ;
CHAIT, LA ;
OBRIEN, BM ;
HURLEY, JV .
PLASTIC AND RECONSTRUCTIVE SURGERY, 1978, 61 (02) :256-267
[36]   Management of No-Reflow Phenomenon in the Catheterization Laboratory [J].
Rezkalla, Shereif H. ;
Stankowski, Rachel V. ;
Hanna, Jennifer ;
Kloner, Robert A. .
JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (03) :215-223
[37]   Pathophysiology, Diagnosis, and Management of the No-Reflow Phenomenon [J].
Allencherril, Joseph ;
Jneid, Hani ;
Atar, Dan ;
Alam, Mahboob ;
Levine, Glenn ;
Kloner, Robert A. ;
Birnbaum, Yochai .
CARDIOVASCULAR DRUGS AND THERAPY, 2019, 33 (05) :589-597
[38]   ROLE OF STAGNATING BLOOD IN THE NO-REFLOW PHENOMENON [J].
ROSEN, HM ;
SLIVJAK, MJ ;
MCBREARTY, FX .
SURGICAL FORUM, 1984, 35 :601-603
[39]   Paving the way for improving no-reflow phenomenon [J].
Senior, Roxy .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 277 :20-21
[40]   No-Reflow Phenomenon: Maintaining Vascular Integrity [J].
Kloner, Robert A. .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2011, 16 (3-4) :244-250